PAA 2.78% 18.5¢ pharmaust limited

Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-125

  1. 1,063 Posts.
    lightbulb Created with Sketch. 85
    Hi .. unscientific musings , don’t listen to me .. I suspect that the investigators were interested in this biomarker because they saw positive non biomarker signs in patient and positive other biomarker indications & were …..

    1. hoping that it may have reduced
    2. Ensuring it had not increased

    The absence of 1 may not be a problem, and may be achievable from earlier intervention. If we can deliver stasis / stability/ lack of deterioration, or a marked reduction in that rate, then we still have a blockbuster and patient has much improved treatment option.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.005(2.78%)
Mkt cap ! $73.24M
Open High Low Value Volume
18.5¢ 19.0¢ 18.3¢ $334.1K 1.802M

Buyers (Bids)

No. Vol. Price($)
2 111778 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 104266 4
View Market Depth
Last trade - 16.10pm 16/05/2024 (20 minute delay) ?
Last
18.5¢
  Change
0.005 ( 2.78 %)
Open High Low Volume
18.5¢ 19.0¢ 18.0¢ 1184237
Last updated 15.57pm 16/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.